ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1775

IgG4-Related Disease, Clinical Series on Chilean Patients

Carolina Cuéllar1, Oscar Neira2,3, Alejandra Herrera4, Miguel Gutérrez5, Fabián Elgueta6, Pamela Wurmann6, Bellanides Mansilla4,7, Javier Basualdo2,8, Jorge Vega5, Daniel Erlij2, Cristián Labarca3, Cristián Vergara5, Verónica Mezzano9,10, Paula Pastenes11, Lilith Stange12, Susana Michalland2, Francisco Silva3, Aquiles Jara13, I. Annelise Goecke6, Carolina Llanos9, María Badilla2, Rodrigo Tagle13, Paula Burgos9, Mirentxu Iruretagoyena9, Patricio Sandoval14, Cristina Fernández15 and Carolina Landeros16, 1Rheumatology Section., Hospital del Salvador, Universidad de Chile., SANTIAGO, Chile, 2Rheumatology Section., Hospital del Salvador, Universidad de Chile., Santiago, Chile, 3Rheumatology Unit, Clinica Alemana de Santiago. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile, 4Rheumatology Departament, Pontificia Universidad Católica de Chile., Santiago, Chile, 5Hospital Naval Almirante Nef, Viña del Mar., Viña del Mar, Chile, 6Rheumatology Section, Hospital Clínico Universidad de Chile, Santiago, Chile, 7Hospital Clínico Magallanes, Punta Arenas, Chile, 8Clínica Santa María de Santiago., Santiago, Chile, 9Rheumatology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, 10Clínica Las Condes., Santiago, Chile, 11Hospital Carlos Van Buren, Valparaíso, Chile, 12Clínica Ciudad del Mar, Viña del Mar, Chile, 13Nephrology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, 14Neurology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, 15Instituto Nacional del Tórax., Santiago, Chile, 16Internal Medicine Service., Hospital del Salvador, Universidad de Chile., Santiago, Chile

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Clinical, IgG4 Related Disease and treatment

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

IgG4-related disease (IgG4-RD) is a chronic fibroinflammatory condition that can affect almost any organ. Gold standard for diagnosis, biopsy, can shows lymphoplasmacytic infiltration, storiform fibrosis, obliterative phlebitis and IgG4+ plasma cell infiltrate. High serum IgG4 levels is observed only in 50% of patients. Disease is more frequent in males, around 60 years old, affecting one or multiple organs with subacute development of tumors or organomegaly. Lymphadenopathies are common, and 40% of patients have a history of allergies. Umehara’s diagnostic criteria (2012), based on clinical features, serum IgG4 levels and histopathology are the most accepted. Disease was described in 2003, and Chilean reports are scarce.

We describe clinical, laboratory, histopathology findings, and treatment on Chilean IgG4-RD patients.

Methods:

We analyzed retrospectively clinical records of 48 patients with IgG4-RD from nine medical centers. Patients with possible, probable and definitive diagnosis, according to Umehara criteria, were included.

Results:

Our cohort was 56% male, with a mean age of 52 (18-76) years. Histological confirmation of IgG4-RD was obtained in 44 of 45 patients who underwent a biopsy. Twenty-three percent of patients had allergic background, 27% had eosinophilia and 43% had elevated plasma levels of IgG4 (≥ 135 mg/dl). The clinical involvement was: pleural and lung disease 38%, kidney 27%, orbital pseudotumor 25%, lymphadenopathy 21%, retroperitoneal fibrosis 19%, aortitis 19%, sialoadenitis 17%, pancreas 17%, pericardium 15% and meninges in 8%. There were three patients with hypophysitis and two with mediastinal fibrosis.

Multiple organ involvement (≥2 organs), observed in 69%, was significantly more frequently in males (p<0.05). There was a statistically significant association between renal disease and low complement levels (p<0.01). All patients who had renal or pulmonary disease had multiple organ involvement. Multiple organ involvement was not related with immunosuppressive treatment requirement.

Pathology confirmation, in 44 patients, showed: lymphoplasmacytic infiltrate in 43 (98%), storiform fibrosis in 29 (66%) and none had obliterative phlebitis. All tissues had diagnostic IgG4 (+) immunohistochemical staining. Storiform fibrosis was present in all lung and kidney biopsy, but only half of salivary gland, orbital and retroperitoneal tissue.

Regarding treatment, all patients received glucocorticoids. In 30 patients (63%) was required immunosuppressive treatment: azathioprine, followed by methotrexate and mycophenolate mofetil were drugs most used. Rituximab was used in 8 patients. Clinical response was good, but one patient dies because extensive mediastinal disease.

Conclusion:

IgG4-RD in Chilean patients is similar that described elsewhere. In most of patients serum levels of IgG4 were normal, then biopsy was essential to diagnosis. Multiple organ involvement was frequent, being pleuropulmonary, kidney, orbital and lymph node most usual localizations. Renal and pulmonary localization occurred always in context of multiorganic disease.


Disclosure: C. Cuéllar, None; O. Neira, None; A. Herrera, None; M. Gutérrez, None; F. Elgueta, None; P. Wurmann, None; B. Mansilla, None; J. Basualdo, None; J. Vega, None; D. Erlij, None; C. Labarca, None; C. Vergara, None; V. Mezzano, None; P. Pastenes, None; L. Stange, None; S. Michalland, None; F. Silva, None; A. Jara, None; I. A. Goecke, None; C. Llanos, None; M. Badilla, None; R. Tagle, None; P. Burgos, None; M. Iruretagoyena, None; P. Sandoval, None; C. Fernández, None; C. Landeros, None.

To cite this abstract in AMA style:

Cuéllar C, Neira O, Herrera A, Gutérrez M, Elgueta F, Wurmann P, Mansilla B, Basualdo J, Vega J, Erlij D, Labarca C, Vergara C, Mezzano V, Pastenes P, Stange L, Michalland S, Silva F, Jara A, Goecke IA, Llanos C, Badilla M, Tagle R, Burgos P, Iruretagoyena M, Sandoval P, Fernández C, Landeros C. IgG4-Related Disease, Clinical Series on Chilean Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/igg4-related-disease-clinical-series-on-chilean-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/igg4-related-disease-clinical-series-on-chilean-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology